InnoPharmax Inc. (4172)
Market Closed
16 Oct, 05:30 AM
TWSE 
JPX Primary TWSE NT$
9. 47
-0.52
-5.2052%
NT$
- Market Cap
- P/E Ratio
88% Div Yield
177,190 Volume
- Eps
NT$ 9.99
Previous Close Want to track 4172 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
InnoPharmax Inc. (4172) Statistics
Valuation metrics
Market Cap -
Enterprise value 942.51M
Trailing P/E (ttm) -5.15
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 16.55
Price/Book (mrq) 2.08
Enterprise Value/Revenue 13.97
Enterprise Value/EBITDA -5.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 289.81K
Average volume (90 days) 175.63K
Price summary
52-Week low 9.47
52-Week high 23.25
Beta -
50-Day moving average 10.55
200-Day moving average 12.07
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 507:500
Last split Date 7 Apr 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.02%
Operating margin -2.86%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.58
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.75
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.27
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 6.42%
Book value per share (mrq) 4.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
